Margaret R. Brown - Concepedia

Author

Margaret R. Brown

National Institute of Allergy and Infectious Diseases ORCID

Also Known As

M BROWN, M Brown, M. Brown, M.R. Brown, MARGARET BROWN, Margaret Brown, Margaret R Brown, Margaret R. Brown, Margaret R. Brown

Publications

6.6K

Citations

H-Index

Concepts

All Affiliations

National Institute of Allergy and Infectious Diseases National Institutes of Health National Institutes of Health Clinical Center National Cancer Institute Center for Cancer Research

About

Margaret R. Brown is an author at National Institute of Allergy and Infectious Diseases specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	21	2.1K
2	Allergy	5	5	511
3	Engineering	1	1	13
4	Health Sciences	1	1	89
5	Natural Sciences	1	1	14

Margaret R. Brown

Publications

6.4K

Citations

H-Index

Page 1

	Year	Citations
Adult-Onset Immunodeficiency in Thailand and Taiwan Sarah Browne, Peter D. Burbelo, Ploenchan Chetchotisakd, New England Journal of Medicine	2012	526
Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets Claude Sportès, Frances T. Hakim, Sarfraz Memon, The Journal of Experimental Medicine	2008	462
Pulmonary Nontuberculous Mycobacterial Disease Richard D. Kim, David E. Greenberg, Mary Ehrmantraut, American Journal of Respiratory and Critical Care Medicine	2008	440
Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia Ashish Jain, Chi Adrian, Shiyung Liu, Nature Immunology Specific Missense MutationsMendelian DisorderNemo ResultGenetic DisorderGenetics	2001	392
Distinctions Between CD8+ and CD4+ T-Cell Regenerative Pathways Result in Prolonged T-Cell Subset Imbalance After Intensive Chemotherapy Crystal L. Mackall, Thomas A. Fleisher, Margaret R. Brown, Blood	1997	382
Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) is a disorder of innate immunity and Th1 activation responsive to IL-1 blockade S Stojanov, Sivia Lapidus, Puja Chitkara, Proceedings of the National Academy of Sciences ImmunodeficienciesInnate Immune SystemImmunologyPathologyInnate Immunity	2011	283
Treatment of Chronic Granulomatous Disease with Nonmyeloablative Conditioning and a T-Cell–Depleted Hematopoietic Allograft Mitchell E. Horwitz, A. John Barrett, Margaret R. Brown, New England Journal of Medicine	2001	273
Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome Amy D. Klion, Jamie Robyn, Cem Akin, Blood	2003	240
Phase I Study of Recombinant Human Interleukin-7 Administration in Subjects with Refractory Malignancy Claude Sportès, Rebecca Babb, Michael Krumlauf, Clinical Cancer Research	2010	214
Anti-IFN-γ Autoantibodies in Disseminated Nontuberculous Mycobacterial Infections Smita Y. Patel, Li Ding, Margaret R. Brown, The Journal of Immunology Anti-ifn-gamma IggImmunologyMedical MicrobiologyMolecular DefectIfn-gamma/il-12 Axis	2005	204

Page 1